PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1999 | 3 |
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 3 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 6 |
| 2007 | 9 |
| 2008 | 47 |
| 2009 | 64 |
| 2010 | 95 |
| 2011 | 84 |
| 2012 | 54 |
| 2013 | 54 |
| 2014 | 65 |
| 2015 | 57 |
| 2016 | 50 |
| 2017 | 40 |
| 2018 | 41 |
| 2019 | 59 |
| 2020 | 43 |
| 2021 | 47 |
| 2022 | 59 |
| 2023 | 26 |
| 2024 | 27 |
| 2025 | 65 |
| 2026 | 63 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Prostate"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Primary BPH Stromal Cell Cultures Exhibit Heightened Androgen-Responsiveness.
- Chen W, Dong F, Askarpour MR, Pascal LE, Dhir R, Chandran U, Jacobs BL, DeFranco DB, Yoshimura N, Wang Z.
- Prostate. 2026 Aug 30;86(15):1508-1517. doi: 10.1002/pros.70239.
- PMCID: PMC13656324
Chen W, et al.Prostate. 2026.PMCID: PMC13656324 -
Natural History of PI-RADS 3 Lesions on Serial Prostate mpMRI.
- Bashi T, Rubinstein Y, Kidron A, Marom R, Rand Y, Atias M, Barnes S, Fahoum I, Keren-Paz G, Sofer M, Yossepowitch O, Dekalo S, Beri A, Mano R.
- Prostate. 2026 Aug 25;86(15):1500-1507. doi: 10.1002/pros.70240.
- PMCID: PMC13656325
Bashi T, et al.Prostate. 2026.PMCID: PMC13656325 -
Longitudinal measurement of subcutaneous and intratibial human prostate cancer xenograft growth and response to ionizing radiation by plasma Alu and LINE-1 ctDNA: A comparison to standard methods.
- Mishra A, Zennami K, Velarde E, Thorek DLJ, Yegnasubramanian S, DeWeese TL, Lupold SE.
- Prostate. Author manuscript. 2021 May 25;81(11):745-753. doi: 10.1002/pros.24171.
- PMCID: PMC13579567
Mishra A, et al.Prostate. Author manuscript. 2021.PMCID: PMC13579567 -
Directed Evolution Restored Castrate Sensitivity in a Patient With Castrate Resistant Metastatic Prostate Cancer.
- Gatenby RA, Anderson ARA, Brown JS, Gallaher J, Krolick J, Lemanne D.
- Prostate. Author manuscript. 2025 Aug 28;85(16):1562-1567. doi: 10.1002/pros.70038.
- PMCID: PMC13573715
Gatenby RA, et al.Prostate. Author manuscript. 2025.PMCID: PMC13573715 -
Treatment of Hot Flashes in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy.
- Schaldemose EL, Poulsen MH, Nørby B, Madsen CV.
- Prostate. 2026 Aug 2;86(14):1391-1403. doi: 10.1002/pros.70229.
- PMCID: PMC13526409
Schaldemose EL, et al.Prostate. 2026.PMCID: PMC13526409 -
Comparisons of Novel Risk Stratification Models to the Current cT1a/b Staging in Incidental Prostate Cancer.
- Scheipner L, Baudo A, Jannello LMI, Siech C, Angelis M, Bello FD, Tian Z, Saad F, Shariat SF, Briganti A, Chun FKH, Carmignani L, Cobelli O, Longo N, Mischinger J, Ahyai S, Karakiewicz PI.
- Prostate. 2026 Aug 2;86(14):1456-1460. doi: 10.1002/pros.70221.
- PMCID: PMC13526406
Scheipner L, et al.Prostate. 2026.PMCID: PMC13526406 -
Clinical Impact of Gleason Pattern 5 on Doublet Versus Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer.
- Fujimoto S, Morita T, Yamamoto Y, Inamoto T, Tamura K, Yoshikawa Y, Maenosono R, Takeuchi A, Takahara K, Sugiyama S, Komura K, Yanagisawa T, Fukuokaya W, Kimura T, Fujita K.
- Prostate. 2026 Aug 2;86(14):1461-1469. doi: 10.1002/pros.70230.
- PMCID: PMC13526412
Fujimoto S, et al.Prostate. 2026.PMCID: PMC13526412 -
Management of De Novo miN1 Prostate Cancer in the PSMA-PET Era.
- McMaster T, Louey CYM, Santucci J, Hobson C, Chen DD, Sathianathen N, Ischia J, Bolton DM, Lawrentschuck N, Murphy DG, Siva S, Perera M.
- Prostate. 2026 Aug 2;86(14):1404-1412. doi: 10.1002/pros.70231.
- PMCID: PMC13526415
McMaster T, et al.Prostate. 2026.PMCID: PMC13526415 -
Predictive Value of [-2]proPSA-Related Indices for Prostate Cancer Detection Years Before Prostate-Specific Antigen Elevation: Insights From a Five-Year Longitudinal Screening Cohort.
- Sekine Y, Fujizuka Y, Nakazawa S, Tsuji Y, Ohtsu A, Miyazawa Y, Arai S, Nomura M, Koike H, Matsui H, Ito K, Suzuki K.
- Prostate. 2026 Aug 2;86(14):1470-1476. doi: 10.1002/pros.70232.
- PMCID: PMC13526410
Sekine Y, et al.Prostate. 2026.PMCID: PMC13526410 -
Evaluation of [225Ac]Ac-PSMA-617 vis-a-vis Rechallenge [177Lu]Lu-PSMA-617 PRLT Versus Cabazitaxel or Oral Metronomic Chemotherapy in mCRPC: An Observational Analysis of Outcome and Toxicity Profiles in a Real-World Clinical Scenario.
- Agrawal R, Parghane RV, Joshi A, Prabhash K, Basu S.
- Prostate. 2026 Jul 26;86(14):1443-1455. doi: 10.1002/pros.70228.
- PMCID: PMC13526414
Agrawal R, et al.Prostate. 2026.PMCID: PMC13526414